Showing posts with label Drug therapy. Show all posts
Showing posts with label Drug therapy. Show all posts

Wednesday, 12 August 2015

Too much medicine - Big Ideas

Too much medicine - Big Ideas

A recent lecture in the Sydney Ideas series was entitled Highlights of too much medicine: exploiting fear for the pursuit of profit.  Retired GP Iona Heath is concerned that, despite the best of intentions, modern medicine may be doing more harm than good. She examined and critiqued the health system and argued that greed and profit are at the centre of a self perpetuating cycle of fear, over diagnosis and over servicing.
ABC's Big Ideas recorded highlights of the talk and you can listen to it or download it at their website here.  You can also read an essay by Heath published in the BMJ late last year, entitled Role of fear in overdiagnosis and overtreatment—an essay by Iona Heath

Iona Heath's talk was presented by the School of Public Health, University of Sydney, Sydney Ideas and the Centre for Research in Evidence Based Practice - Bond University on 5th Aug 2015.

Wednesday, 17 June 2015

National opioid pharmacotherapy statistics 2014

The Australian Institute of Health and Welfare has released the National opiod pharmacotherapy statistics for 2014.  Dependence on opioid drugs is associated with a range of health and social problems and this bulletin presents information on the clients receiving opioid pharmacotherapy treatment, the doctors prescribing these drugs, and the dosing points that clients attend to receive their medication.

On a snapshot day in 2014, over 48,000 clients received pharmacotherapy treatment for their opioid dependence at 2,432 dosing points around Australia. As in previous year, methadone was the most common pharmacotherapy drug, with around two-thirds (67%) of clients treated with this drug. There were 2,319 prescribers of opioid pharmacotherapy drugs, an increase of 15% from 2013.

Wednesday, 13 May 2015

Statins and diabetes

Statins and diabetes

As a cholesterol-lowering medication, statins have been proven to be effective at reducing cardiovascular risk, if it is significantly raised.  Rethinking Statins, a program on ABC Radio National's Health Report, discusses emerging suspicions that statins may actually increase the risk of developing diabetes.

Norman Swan interviewed Naveed Sattar, Professor of Metabolic Medicine at the University of Glasgow.  Sattar and his colleagues looked at a range of randomised clinical trials and related the risk of diabetes in those who were given a statin versus a placebo.  They found that if you take any statin your risk for diabetes increases about 10% to 12%. For those on a higher dose of statin, the risk increases another 10% to 15%.

But Sattar cautions against people stopping taking statins, "We can use this new evidence in a positive way. When patients are prescribed statins, we would suggest to them that the statin might protect their heart but that doesn't necessarily mean that they can forego lifestyle changes. And in fact, the fact the statins increase diabetes risk ever so slightly suggests that actually they have more reason to take lifestyle seriously and not less."

Listen online, or read the transcript, at the link above.

Wednesday, 6 May 2015

Respiratory medication use in Australia 2003-2013


A report just published by the Australian Institute of Health and Welfare describes the patterns of dispensing of respiratory medications in Australia through a detailed analyses of Pharmaceutical Benefits Scheme (PBS) data, as well as other sources, to draw inferences about respiratory medication use among patients with asthma and COPD. 

Respiratory medication use in Australia 2003-2013: treatment of asthma and COPD provides evidence of "substantial over- and under-use of certain classes of medications for management of asthma and COPD. ...Our findings indicate the potential both for better health outcomes and for cost savings to patients and governments by better targeting of treatment for asthma and COPD."
 Polypharmacy in older Australians

Polypharmacy in older Australians

A study just published in Medical Journal of Australia has revealed that about 24% of patients aged 70 years or over had 10 or more routinely prescribed medicines on hospital admission.  The authors of Polypharmacy among inpatients aged 70 years or older in Australia examined records from 2005 to 2010 and compared the number of medicines recorded at hospital admission to the number recorded at hospital discharge.  They found there was no change in either the number or type of medicines prescribed to the patient. The authors concluded that treating clinicians could be doing more to rationalise the number of drugs prescribed during that patient's hospital stay.

Polypharmacy among inpatients aged 70 years or older in Australia.
Ruth E Hubbard, Nancye M Peel, Ian A Scott, Jennifer H Martin, Alesha Smith, Peter I Pillans, Arjun Poudel and Leonard C Gray
Med J Aust 2015; 202 (7): 373-377. doi:10.5694/mja13.00172

Wednesday, 13 November 2013

New US guidelines on cholesterol treatment

New US guidelines on cholesterol treatment

Following on from the recent Australian media debate over the use of statins, the major heart organisations in the USA have just released new guidelines, published in the Journal of the American College of Cardiology:  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [J Am Coll Cardiol. 2013;():. doi:10.1016/j.jacc.2013.11.005].

A useful summary of the changes in the US can be found in Tuesday's New York Times article, Experts reshape treatment guide for cholesterol, by Gina Kolata.  Doctors are encouraged to prescribe statins to high risk patients (those who have diabetes or have had a heart attack), and to those who have very high levels of LDL cholesterol.  Others should be considered for statin therapy if, using a new risk calculator their risk of a heart attack or stroke in the next 10 years is at least 7.5 percent.  There is less emphasis on lowering cholesterol by specific amounts, and as Kolata reports, "It is not clear whether more or fewer people will end up taking the drugs under the new guidelines, experts said. Many women and African-Americans, who have a higher-than-average risk of stroke, may find themselves candidates for treatment, but others taking statins only to lower LDL cholesterol to target levels may no longer need them."

Tuesday, 5 November 2013

Cholesterol and statins debate

Cholesterol and statins debate

The ABC recently aired a two-part program on Catalyst entitled The Heart of the Matter.  The first program, Dietary Villains, questioned the role of saturated fats in causing high cholesterol and cardiovascular disease, and the second program, Cholesterol Drug War, asked if statins really reduce your risk of heart disease.  The result has been consternation among some of Australia's medical community, with the ABC's own health specialist Norman Swan claiming that the Catalyst program could cause people to die if they gave up taking statins on the basis of this program (see the Sydney Morning Herald report on 4 November).

The ABC's Health Report (presented by Norman Swan) made an alternative case in their program this week, The Cholesterol and Statin Debate, which included an interview with Professor Peter Clifton.  Another interesting article which attempts to unravel the arguments and includes links to clinical trials and other evidence-based material was published this week in The Conversation by Justin Coleman from Griffith University - Viewing Catalyst's cholesterol programs through the sceptometer . Be sure to scroll down to the comments below where the conversation continues.